AHA yesterday submitted comments to the Centers for Medicare & Medicaid Services in response to a request for information on the Medicare Advantage program. AHA in its letter raised concerns over certain Medicare Advantage organization practices and policies that restrict or delay access to care; provided considerations for health equity, behavioral health access, and post-acute care services; outlined implications for continued enrollment growth in the program; and described the unique value that integrated health systems provide in serving Medicare Advantage beneficiaries. In addition, AHA provided a series of “specific recommendations that we believe are necessary to hold [Medicare Advantage organizations] accountable for complying with the law, protecting beneficiaries from harm and ensuring the sustainability of the Medicare program.”

Headline
The Centers for Medicare & Medicaid Services Nov. 5 published a final rule to codify the Medicare Drug Price Negotiation Program beginning in 2029. The…
Headline
The estimated average monthly premium for Medicare Part D stand-alone prescription drug plans is $51 for 2027, a 50% increase from $34 in 2026, for enrollees…
Headline
The Centers for Medicare & Medicaid Services released a proposed rule Oct. 16 seeking to codify regulations that will improve the accuracy of Medicare…
Headline
The Centers for Medicare & Medicaid Services announced that it will exercise enforcement discretion for inpatient rehabilitation facility admissions from…
Headline
The Centers for Medicare & Medicaid Services has released 2027 Medicare Advantage plan information, including star ratings, through the Medicare Plan…
Headline
The AHA provided comments to the Medicare Payment Advisory Commission Oct. 2 on a discussion from the commission’s September meeting on its examination of…